RIOK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 2.19819999999205E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
4.803600E-01
Normal-vs-Stage2
2.32089999996354E-06
Normal-vs-Stage3
3.274000E-01
Normal-vs-Stage4
1.921610E-01
Stage1-vs-Stage2
1.492960E-01
Stage1-vs-Stage3
4.126800E-01
Stage1-vs-Stage4
2.535400E-01
Stage2-vs-Stage3
6.594800E-01
Stage2-vs-Stage4
3.083200E-01
Stage3-vs-Stage4
4.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
1.87680000000023E-05
Normal-vs-AfricanAmerican
1.051350E-01
Normal-vs-Asian
4.355500E-02
Caucasian-vs-AfricanAmerican
8.853400E-01
Caucasian-vs-Asian
9.263800E-01
AfricanAmerican-vs-Asian
8.572400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
5.40830000006487E-07
Normal-vs-Female
5.57089999999594E-05
Male-vs-Female
1.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
9.582600E-01
Normal-vs-Age(41-60Yrs)
5.05609999978951E-07
Normal-vs-Age(61-80Yrs)
1.57546999999258E-05
Normal-vs-Age(81-100Yrs)
1.891790E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.128590E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.606600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.915030E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.794200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.005400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
2.996300E-03
Normal-vs-Daily Drinker
4.561600E-03
Normal-vs-Weekly Drinker
5.660000E-02
Normal-vs-Occasional Drinker
1.636880E-04
Normal-vs-Social Drinker
8.463500E-02
Non Drinker-vs-Daily Drinker
2.122200E-01
Non Drinker-vs-Weekly Drinker
9.468400E-01
Non Drinker-vs-Occasional Drinker
2.453800E-02
Non Drinker-vs-Social Drinker
5.260200E-01
Daily Drinker-vs-Weekly Drinker
3.510800E-01
Daily Drinker-vs-Occasional Drinker
6.339600E-01
Daily Drinker-vs-Social Drinker
4.310800E-01
Weekly Drinker-vs-Occasional Drinker
1.014210E-01
Weekly Drinker-vs-Social Drinker
6.642200E-01
Occasional Drinker-vs-Social Drinker
1.321640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
1.760210E-01
Normal-vs-Grade 2
6.745800E-02
Normal-vs-Grade 3
1.212230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.176300E-02
Grade 1-vs-Grade 3
4.715700E-02
Grade 1-vs-Grade 4
1.760210E-01
Grade 2-vs-Grade 3
8.498600E-01
Grade 2-vs-Grade 4
6.745800E-02
Grade 3-vs-Grade 4
1.212230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
6.678100E-03
Normal-vs-NonDiabetic
1.18459999998155E-06
Diabetic-vs-NonDiabetic
1.288240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
1.007210E-01
Normal-vs-NoPancreatitis
2.64459999999023E-06
Pancreatitis-vs-NoPancreatitis
4.567400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
1.643350E-03
Normal-vs-N1
9.3042000004484E-07
N0-vs-N1
9.155500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
8.99813556998197E-12
Normal-vs-TP53-NonMutant
6.28459999999498E-05
TP53-Mutant-vs-TP53-NonMutant
8.34250000000258E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap